Halma strengthens its position in specialist healthcare markets with bolt-on acquisitions
02 July 2026
Halma plc, the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, today announces that it has acquired itemedical and Naslund Medical for its Healthcare sector companies SSG and IZI Medical.
These bolt-on acquisitions strengthen Halma’s Healthcare companies in specialist healthcare markets and reflect Halma’s disciplined, long-term approach to M&A, building capabilities within existing operating companies in areas where it has deep expertise.
itemedical is a Dutch provider of digital platforms that integrates real-time patient data and alarms from different medical devices, supporting clinical decision-making and workflow efficiency in hospitals. The acquisition enhances SSG’s digital capabilities and expands its offering in hospital workflow management, supporting growth in a market driven by increasing digitalisation in healthcare systems.
Naslund Medical is a Swedish company specialising in fiducial marker technology used to support targeted cancer treatment. Its core product, Gold Anchor®, enables more precise targeting of tumours during radiation therapy. The acquisition broadens IZI Medical’s radiation oncology offering by adding Gold Anchor® to its existing Visicoil platform, supporting customers with a wider range of premium fiducial marker technologies. Naslund also brings an established international footprint, supporting IZI’s ambition to expand globally.
Marc Ronchetti, Group Chief Executive of Halma, said: “These acquisitions strengthen our existing companies by adding complementary capabilities in markets they know well, supporting their long-term growth while enabling improved patient outcomes. They operate in areas which have attractive long-term growth drivers and provide a strong platform for continued innovation and international expansion. We are pleased to welcome itemedical and Naslund Medical to Halma.”
For further information, please contact:
|
MHP Group |
|
| Oliver Hughes/Rachel Farrington/Ollie Hoare | +44 (0)20 3128 8100 / +44 (0)7817 458 804 |
A copy of this announcement, together with other information about Halma, is available at www.halma.com.
About Halma
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.
Its purpose defines the three broad market areas where it operates:
- Safety: Protecting people, assets and critical infrastructure by addressing safety risks in public, commercial and industrial environments, and supporting a safer, more sustainable future.
- Environmental & Analysis: Monitoring the environment and ensuring the quality and availability of life-critical resources, and enabling scientific research through advanced measurement, analysis and data transmission.
- Healthcare: Meeting the growing demand for healthcare as populations age and chronic conditions rise, by supporting the discovery of new cures, the prevention, diagnosis and treatment of patient conditions, and enabling the delivery of safer, more efficient healthcare.
It employs over 9,000 people in more than 20 countries, with major operations in the UK, Europe, the US and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
Halma has been named as one of Britain’s Most Admired Companies for the past seven years.
For more information see www.halma.com
About itemedical
itemedical is a specialist provider of digital solutions for hospital environments based in The Netherlands. The company develops a vendor-neutral platform that integrates and prioritises patient data from multiple medical devices, supporting clinical decision-making and improving workflow efficiency in healthcare settings. Its technology is embedded in clinical workflows and supports healthcare providers in managing complex patient data more effectively. For more information see www.itemedical.co.uk.
About Naslund Medical
Naslund Medical is a Swedish company specialising in fiducial marker technology used to support targeted cancer treatment. Its core product, Gold Anchor®, enables more precise targeting of tumours during radiation therapy by providing a reliable reference point for clinicians by using rice grain-sized markers. The company’s products are embedded in routine clinical workflows and are used by healthcare providers globally. For more information see www.goldanchormarker.com.
ENDS.
